CSCO
63
5
ROST
60
3
HSY
32
3
JNJ
30
4
AMGN
42
14
NSC
33
6
LOW
42
14
UHS
50
4
JCI
44
7
ED
39
8
IRM
33
5
ESS
44
5
ES
12
3
OXY
42
17
OI
23
3
URBN
67
3
JNPR
59
3
MMM
35
3
CTAS
36
8
LB
16
9
CSCO
63
5
ROST
60
3
HSY
32
3
JNJ
30
4
AMGN
42
14
NSC
33
6
LOW
42
14
UHS
50
4
JCI
44
7
ED
39
8
IRM
33
5
ESS
44
5
ES
12
3
OXY
42
17
OI
23
3
URBN
67
3
JNPR
59
3
MMM
35
3
CTAS
36
8
LB
16
9
Financhill
Back

Alkermes PLC 10K Form

Buy
57

ALKS
Alkermes PLC

Last Price:
$29.71
Seasonality Move:
12.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01 10Q ALKS/Alkermes PLC Quarterly
2023-10-25 10Q ALKS/Alkermes PLC Quarterly
2023-07-26 10Q ALKS/Alkermes PLC Quarterly
2023-04-26 10Q ALKS/Alkermes PLC Quarterly
2022-11-02 10Q ALKS/Alkermes PLC Quarterly
2022-07-27 10Q ALKS/Alkermes PLC Quarterly

Receive ALKS News And Ratings

See the #1 stock for the next 7 days that we like better than ALKS

ALKS Financial Statistics

Sales & Book Value

Annual Sales: $1.7B
Cash Flow: $73.3M
Price / Cash Flow: 15.97
Annual Sales: $7.99
Price / Book: 3.72

Profitability

EPS (TTM): 1.95000
Net Income (TTM): $333.3M
Gross Margin: $1.4B
Return on Equity: 26.09%
Return on Assets: 15.29%

Alkermes PLC Earnings Forecast

Key Alkermes PLC Financial Ratios

  • The Gross Profit Margin over the past 32 years for ALKS is 84.79%.
  • The Selling, General & Administrative Expenses for ALKS have been equal to 41.47% of Gross Profit Margin.
  • The Research & Development expenses have been 16.28% of Revenue.
  • The Interest Expense is 6.47% of Operating Income.
  • The Net Earning history of ALKS is 21.39% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 16 years.

Alkermes PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALKS
CUSIP: G01767
Website: alkermes.com

Debt

Debt-to-Equity Ratio: 0.22
Current Ratio: 3.45
Quick Ratio: 2.82

Price-to-Earnings

Trailing P/E Ratio: 14.15
Forward P/E Ratio: 16.78

ALKS Technical Analysis vs Fundamental Analysis

Buy
57
Alkermes PLC (ALKS) is a Buy

Is Alkermes PLC a Buy or a Sell?

  • Alkermes PLC stock is rated a Buy
    The current Alkermes PLC [ALKS] share price is $29.71. The Score for ALKS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.